Manoussos Perros

Insider Reports History

Location
Waltham, MA
Signature
Elizabeth M. Keiley as Attorney-in-Fact for Manoussos Perros
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Manoussos Perros:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entasis Therapeutics Holdings Inc. President and CEO, Director Common Stock 0 $2.20 11 Jul 2022 Direct
Entasis Therapeutics Holdings Inc. President and CEO, Director Stock Option (right to buy) 0 11 Jul 2022 Direct

Insider Reports Filed by Manoussos Perros

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465922078800-perros-manoussos-2022-07-07 Entasis Therapeutics Holdings Inc. 07 Jul 2022 6 -$123,358 4 President and CEO, Director 11 Jul 2022, 16:08
/report/000110465922005423-perros-manoussos-2022-01-18 Entasis Therapeutics Holdings Inc. 18 Jan 2022 1 $0 4 President and Chief Executive Officer 19 Jan 2022, 15:04
/report/000110465921133627-perros-manoussos-2021-11-02 Entasis Therapeutics Holdings Inc. 02 Nov 2021 1 -$34,410 4 President and CEO, Director 03 Nov 2021, 16:03
/report/000110465921128067-perros-manoussos-2021-10-19 Entasis Therapeutics Holdings Inc. 19 Oct 2021 2 -$38,197 4 President and Chief Executive Officer, Director 20 Oct 2021, 16:14
/report/000110465922023781-perros-manoussos-2021-07-16 Entasis Therapeutics Holdings Inc. 16 Jul 2021 8 $0 4 President and CEO 15 Feb 2022, 15:04